Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compounds and methods for diagnosis and treatment of leishmaniasis

A technology for leishmaniasis and leishmania, which is applied in the field of serum diagnosis and can solve problems such as decreased sensitivity and low reactivity

Inactive Publication Date: 2009-06-24
INFECTIOUS DISEASE RES INST IN
View PDF19 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in Sudan, Ethiopia, and Kenya, the sensitivity of the strip test dropped to 67%, and negative responses to the strip test by ELISA appeared to be associated with lower reactivity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds and methods for diagnosis and treatment of leishmaniasis
  • Compounds and methods for diagnosis and treatment of leishmaniasis
  • Compounds and methods for diagnosis and treatment of leishmaniasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compounds and methods are provided for diagnosing, preventing, treating and detecting leishmaniasis infection and stimulating immune responses in patients are disclosed. The compounds disclosed are include polypeptides and fusion proteins that contain at least one immunogenic portion of one or more Leishmania antigens, or a variant thereof. Additionally, methods of screening a screening library for tandem repeat proteins that have immunogenic properties are disclosed. Vaccines and pharmaceutical compositions comprising polynucleotides, polypeptides, fusion proteins and variants thereof that may be used for the prevention and therapy of leishmaniasis, as well as for the detection of Leishmaniasis infection are described.

Description

[0001] priority claim [0001] This application claims priority to US non-provisional application 11 / 733,440, filed April 10,2007. The foregoing applications are incorporated herein by reference in their entirety. [0002] This application claims priority to US Provisional Application 60 / 744,798, filed April 13,2006. The foregoing applications are incorporated herein by reference in their entirety. [0003] This application claims priority to US Provisional Application 60 / 791,226, filed April 10,2006. The foregoing applications are incorporated herein by reference in their entirety. field of invention [0004] The present invention relates generally to serodiagnosis of Leishmania infection. More particularly the present invention relates to the use of one or more Leishmania polypeptides in methods and diagnostic kits to screen for Leishmania from organisms and blood supplies and to identify those with the potential to develop acute visceral Those individuals with leishman...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/00C07K4/12C07K2/00C07K19/00A61K39/008G01N33/53
CPCY02A50/30
Inventor S·G·里德后藤康之
Owner INFECTIOUS DISEASE RES INST IN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products